Veterinary Medicines

Neosol 145 g/1000 ml Roztwór doustny

Authorised
  • NEOMYCIN SULFATE
Download as PDF

Product identification

Medicine name:
Neosol 145 g/1000 ml Roztwór doustny
Active substance:
  • NEOMYCIN SULFATE
Target species:
  • Chicken (hen)
  • Sheep
  • Turkey
  • Cattle
  • Pig
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • NEOMYCIN SULFATE
    145.00
    gram(s)
    /
    1000.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Chicken (hen)
      • Eggs
        3
        day
      • Meat and offal
        7
        day
    • Sheep
      • Meat and offal
        14
        day
    • Turkey
      • Eggs
        3
        day
      • Meat and offal
        7
        day
    • Cattle
      • Meat and offal
        14
        day
    • Pig
      • Meat and offal
        14
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01G
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetoquinol Biowet Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol Biowet Sp. z o.o.
Responsible authority:
  • URPL
Authorisation number:
  • 0822
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."